A Complete Overview and Guidelines for nCOv-2019 (COVID-19) with Special Reference to Corporate Hospital
Avinash Teli, Azaz Ahmad, Danish Azad, Mohd Ajmal, Shaziya Sheikh and Arvind Kumar
Journal Title:Acta Scientific Microbiology
An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention. On 30 January 2020, World Health Or-ganization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. Meanwhile, several independent research groups have identified that SARS-CoV-2 belongs to β-coronavirus, with highly identical genome to bat coronavirus, pointing to bat as the natural host. These policies included large-scale quarantine, strict controls on travel and extensive monitoring of suspected cases. However, it is unknown whether these policies have had an impact on the epidemic. We sought to show how these control measures impacted the containment of the epidemic. The novel coronavirus uses the same receptor, angio-tensin-converting enzyme 2 (ACE2) as that for SARS-CoV and mainly spreads through the respiratory tract. Importantly, increasingly evidence showed sustained human-to-human transmission, along with many exported cases across the globe. The clinical symptoms of COVID-19 patients include fever, cough, fatigue and a small population of patients appeared gastrointestinal infection symptoms.